Category Archives: Hormone Replacement Therapy

A transgender man can sue a Catholic hospital over a last-minute hysterectomy cancellation, the 1st District Court of Appeal in San Francisco ruled, the Sacramento Bee reported. Evan Minton's procedure was canceled after the patient told a nurse of being transgender, the paper said, citing the lawsuit. Continue reading →

BARCELONA, Spain, Sept. 27, 2019 /PRNewswire/ --The Janssen Pharmaceutical Companies of Johnson & Johnson announced today updated, longer-term results from the pivotal Phase 3 SPARTAN study following a second interim analysis. Treatment with ERLEADA (apalutamide) plus androgen deprivation therapy (ADT) resulted in a 25 percent reduction in the risk of death compared with placebo plus ADT in patients with non-metastatic castration-resistant prostate cancer (nmCRPC) who were at high risk of developing metastases.1 The updated findings showed overall survival (OS) results supported the first interim analysis, despite a crossover of patients receiving placebo to the ERLEADA treatment group.1Results were presented in an oral session at the 2019 European Society for Medical Oncology (ESMO) Annual Congress (abstract #843O), and simultaneously published in Annals of Oncology Continue reading →

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced positive data from the Phase III IMpower110 study evaluating Tecentriq (atezolizumab) as a first-line (initial) monotherapy compared with cisplatin or carboplatin and pemetrexed or gemcitabine (chemotherapy) in advanced non-squamous and squamous non-small cell lung cancer (NSCLC) without ALK or EGFR mutations (wild-type; WT). The study met its primary endpoint in an interim analysis showing that Tecentriq monotherapy improved overall survival (OS) by 7.1 months compared with chemotherapy alone (median OS=20.2 versus 13.1 months; hazard ratio [HR]=0.595, 95% CI: 0.3980.890; p=0.0106) in people with high PD-L1 expression (TC3/IC3-WT). Encouraging OS (18.2 versus 14.9 months; HR=0.717, 95% CI: 0.5200.989) was also observed in people with medium levels of PD-L1 expression (TC2/3 or IC2/3-WT), however these data did not reach statistical significance at this interim analysis. Continue reading →

A transgender man desperate to have his breasts removed says he "can't wait two and a half years" for an NHS spot. Jesse Churchill, 24, came out as non-binary transmasculine - a person who was assigned female at birth, but who identifies with masculinity to a greater extent than with femininity - in 2017 Continue reading →

Hormone replacement therapy is the supplementation of estrogen and progesterone, the two hormones that are depleted during the menopausal phase of a woman's life. In America, the average age of a woman hitting menopause is 51.5 years. Continue reading →

Posted: Sep 20, 2019 / 03:06 PM GMT-0600 / Updated: Sep 20, 2019 / 03:06 PM GMT-0600 September is healthy aging month. Hormone imbalances, childbirth, and aging can very often affect sexual health. This area of health plays an important role in your relationships, confidence, and overall well-being Continue reading →

Richard Messina for ESPN "Mack Wrestles" tells the story of Mack Beggs, an elite wrestler whose love for the sport helped him overcome the stigmas that come with being a transgender athlete. "Mack Wrestles" is an ESPN 30 for 30 short that premiered at the SXSW Film Festival in March. Continue reading →

Crystal Market Research Announced the Research Insights added a new analytical data of Global Hormone Replacement Therapy Hrt Market which focuses on effective strategies of the business framework. It highlights the recent market trends, growth in the past decade, and upcoming opportunities in front of the business. The research methods and tools used to analyze the studies are both primary and secondary research. Continue reading →

The menopause used to be ominously referred to as the change an entire life stage relegated to a euphemism. And, although it directly affects half the population, it has remained a stubbornly taboo topic Continue reading →

College wrestling season is only weeks away, and on Friday ESPN intentionally withheld key information in its celebration of the sport's firsttransgender wrestler. Non-binary ESPN W writer Katie Barnes featured Mackenzie "Mack" Beggs, the girl who wanted to compete in boys' wrestling, but was forced against her will to win her last 92 matches and two state high school girls' championships in Texas. Beggs is now a member of the Life University men's wrestling team that will start its season in a few weeks, and Barnes is riding this story for all it's worth, skipping over some crucial facts Continue reading →